SCHEMBL4930909

SCHEMBL4930909

CCNc1cc(C#N)cc(COc2c(Cl)cc(C(=O)NCC(=O)O)cc2Cl)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MRGPRX4 Q96LA9 4/20 0.40
THRA P10827 1/20 0.38
THRB P10828 1/20 0.38
ALDH1A1 P00352 3/20 0.36
MEN1 O00255 2/20 0.36
RAB9A P51151 2/20 0.36
KMT2A Q03164 2/20 0.36
GAA P10253 2/20 0.36
HPGD P15428 2/20 0.36
NPC1 O15118 1/20 0.36
ABL1 P00519 1/20 0.36
LMNA P02545 1/20 0.36
MAPT P10636 1/20 0.36
RIN1 Q13671 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
EGLN1 Q9GZT9 3/20 0.36
HSD17B10 Q99714 1/20 0.36
ITGB3 P05106 1/20 0.35
ITGA2B P08514 1/20 0.35
KDM4E B2RXH2 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4929539 0.92 MRGPRX4 (0.39) MRGPRX4ALDH1A1MEN1RAB9AKMT2A
SCHEMBL4931752 0.90 THRB (0.47) MRGPRX4THRATHRBMEN1RAB9A
SCHEMBL4930880 0.90 MRGPRX4 (0.41) MRGPRX4ALDH1A1MEN1RAB9AKMT2A
SCHEMBL5110916 0.88 MRGPRX4 (0.39) MRGPRX4ALDH1A1MEN1RAB9AKMT2A
SCHEMBL5717874 0.88 MRGPRX4 (0.36) MRGPRX4THRATHRBALDH1A1MEN1
SCHEMBL4929549 0.88 MRGPRX4 (0.40) MRGPRX4ALDH1A1MEN1RAB9AKMT2A
SCHEMBL5110614 0.88 MRGPRX4 (0.40) MRGPRX4ALDH1A1MEN1RAB9AKMT2A
SCHEMBL4926987 0.86 THRA (0.41) MRGPRX4THRATHRBALDH1A1MEN1
SCHEMBL4358827 0.85 THRA (0.41) MRGPRX4THRATHRBALDH1A1MEN1
SCHEMBL5106743 0.85 KMT2A (0.39) MRGPRX4THRATHRBALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080221210-A1 Thyroid Receptor Agonists KARO BIO AB (SE) 2008-09-11 US disclosed
EP-1732533-A1 THYROID RECEPTOR AGONISTS KARO BIO AB (SE) 2006-12-20 EP disclosed
WO-2005092317-A1 THYROID RECEPTOR AGONISTS KARO BIO AB (SE) 2005-10-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080221210-A1 Thyroid Receptor Agonists TSHR, TRHR, THRA MRGPRX4 119/4885THRA 3/4885THRB 4/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.